SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Amgen Inc – ‘10-Q’ for 9/30/14 – ‘R59’

On:  Wednesday, 10/29/14, at 4:46pm ET   ·   For:  9/30/14   ·   Accession #:  318154-14-22   ·   File #:  0-12477

Previous ‘10-Q’:  ‘10-Q’ on 8/5/14 for 6/30/14   ·   Next:  ‘10-Q’ on 4/27/15 for 3/31/15   ·   Latest:  ‘10-Q’ on 5/3/24 for 3/31/24

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

10/29/14  Amgen Inc                         10-Q        9/30/14   77:13M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    751K 
 2: EX-10.18    Agreement Between Amgen Inc. and Mr. David W.       HTML     87K 
                Meline                                                           
 3: EX-31       Rule 13A-14(A) Certifications                       HTML     36K 
 4: EX-32       Section 1350 Certifications                         HTML     25K 
51: R1          Document and Entity Information                     HTML     40K 
40: R2          Condensed Consolidated Statements of Income         HTML     86K 
                (Unaudited)                                                      
49: R3          Condensed Consolidated Statements of Comprehensive  HTML     47K 
                Income (Unaudited)                                               
54: R4          Condensed Consolidated Balance Sheets (Unaudited)   HTML    100K 
71: R5          Condensed Consolidated Balance Sheets (Unaudited)   HTML     29K 
                (Parenthetical)                                                  
42: R6          Condensed Consolidated Statements of Cash Flows     HTML    112K 
                (Unaudited)                                                      
48: R7          Summary of significant accounting policies          HTML     35K 
36: R8          Restructuring                                       HTML     64K 
26: R9          Business combinations                               HTML     58K 
72: R10         Income taxes                                        HTML     33K 
56: R11         Earnings per share                                  HTML     55K 
55: R12         Available-for-sale investments                      HTML    225K 
61: R13         Inventories                                         HTML     31K 
62: R14         Goodwill and other intangible assets                HTML     87K 
59: R15         Financing arrangements                              HTML     76K 
63: R16         Stockholders' equity                                HTML    148K 
50: R17         Fair value measurement                              HTML    224K 
53: R18         Derivative instruments                              HTML    172K 
58: R19         Contingencies and commitments                       HTML     34K 
77: R20         Summary of significant accounting policies          HTML     52K 
                (Policies)                                                       
67: R21         Restructuring (Tables)                              HTML     62K 
45: R22         Business combinations (Tables)                      HTML     46K 
57: R23         Earnings per share (Tables)                         HTML     52K 
47: R24         Available-for-sale investments (Tables)             HTML    225K 
19: R25         Inventories (Tables)                                HTML     30K 
68: R26         Goodwill and other intangible assets (Tables)       HTML     76K 
74: R27         Financing arrangements (Tables)                     HTML     75K 
31: R28         Stockholders' equity (Tables)                       HTML    140K 
30: R29         Fair value measurement (Tables)                     HTML    200K 
34: R30         Derivative instruments (Tables)                     HTML    156K 
35: R31         Summary of significant accounting policies          HTML     25K 
                (Details)                                                        
37: R32         Restructuring (Details Textual)                     HTML     35K 
17: R33         Restructuring (Details)                             HTML     40K 
65: R34         Restructuring (Details 1)                           HTML     32K 
44: R35         Business combinations (Details)                     HTML     27K 
46: R36         Business combinations (Details 1)                   HTML     60K 
22: R37         Business combinations (Details 2)                   HTML     27K 
76: R38         Business combinations (Details Textual)             HTML     57K 
11: R39         Income taxes (Details)                              HTML     37K 
38: R40         Earnings per share (Details)                        HTML     44K 
70: R41         Available-for-sale investments (Details)            HTML     56K 
21: R42         Available-for-sale investments (Details 1)          HTML     39K 
29: R43         Available-for-sale investments (Details 2)          HTML     42K 
33: R44         Available-for-sale investments Available-for-sale   HTML     52K 
                investments (Details 3)                                          
41: R45         Available-for-sale investments (Details Textual)    HTML     33K 
16: R46         Inventories (Details)                               HTML     33K 
25: R47         Goodwill and other intangible assets (Details)      HTML     29K 
13: R48         Goodwill and other intangible assets (Details 1)    HTML     46K 
69: R49         Goodwill and other intangible assets (Details       HTML     45K 
                Textual)                                                         
20: R50         Financing arrangements (Details)                    HTML    116K 
66: R51         Stockholders' equity (Details Textual)              HTML     33K 
23: R52         Stockholders' equity (Details 1)                    HTML     86K 
39: R53         Stockholders' equity (Details 2)                    HTML     45K 
12: R54         Fair value measurement (Details)                    HTML    140K 
15: R55         Fair value measurement Fair value measurement       HTML     28K 
                (Details 1)                                                      
32: R56         Fair value measurements (Details Textual)           HTML     50K 
18: R57         Derivative instruments (Details)                    HTML     27K 
73: R58         Derivative instruments (Details 1)                  HTML     27K 
43: R59         Derivative instruments (Details 2)                  HTML     39K 
60: R60         Derivative instruments (Details 3)                  HTML     25K 
24: R61         Derivative instruments (Details 4)                  HTML     41K 
27: R62         Derivative instruments (Details Textual)            HTML     49K 
64: R63         Contingencies and commitments (Details)             HTML     22K 
75: XML         IDEA XML File -- Filing Summary                      XML    113K 
14: EXCEL       IDEA Workbook of Financial Reports                  XLSX    257K 
28: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   2.31M 
 5: EX-101.INS  XBRL Instance -- amgn-20140930                       XML   3.59M 
 7: EX-101.CAL  XBRL Calculations -- amgn-20140930_cal               XML    234K 
 8: EX-101.DEF  XBRL Definitions -- amgn-20140930_def                XML    665K 
 9: EX-101.LAB  XBRL Labels -- amgn-20140930_lab                     XML   1.62M 
10: EX-101.PRE  XBRL Presentations -- amgn-20140930_pre              XML    969K 
 6: EX-101.SCH  XBRL Schema -- amgn-20140930                         XSD    183K 
52: ZIP         XBRL Zipped Folder -- 0000318154-14-000022-xbrl      Zip    262K

‘R59’   —   Derivative instruments (Details 2)

This is an IDEA Financial Report.  [ Alternative Formats ]

 
v2.4.0.8
Derivative instruments (Details 2) (USD $)
In Millions, unless otherwise specified
 3 Months Ended 9 Months Ended
Derivative Instruments Gain Loss [Line Items]        
Product sales $ 4,848 $ 4,647 $ 14,153 $ 13,393
Interest and other income, net 140 72 377 332
Interest expense, net (269) (257) (810) (761)
Income before income taxes 1,337 1,503 4,299 4,251
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
        
Derivative Instruments Gain Loss [Line Items]        
Product sales 5 6 5 9
Interest and other income, net (179) 153 (117) 25
Interest expense, net (1) 0 (1) (1)
Income before income taxes (175) 159 (113) 33
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | Cash flow hedge [Member]
        
Derivative Instruments Gain Loss [Line Items]        
Income before income taxes (175) 159 (113) 33
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | Cash flow hedge [Member] | Foreign currency contracts [Member]
        
Derivative Instruments Gain Loss [Line Items]        
Product sales 5 6 5 9
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | Cash flow hedge [Member] | Cross currency swap contracts [Member]
        
Derivative Instruments Gain Loss [Line Items]        
Interest and other income, net (179) 153 (117) 25
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | Cash flow hedge [Member] | Forward interest rate contracts [Member]
        
Derivative Instruments Gain Loss [Line Items]        
Interest expense, net $ (1) $ 0 $ (1) $ (1)

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:10/29/144
For Period end:9/30/14
9/30/1310-Q
 List all Filings 
↑Top
Filing Submission 0000318154-14-000022   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Wed., May 15, 12:51:22.1am ET